Effectiveness and safety of lumbar erector spinae plane block versus no locoregional block in hip surgery: a randomized controlled trial.
文献摘要
Background Ultrasound-guided regional anaesthesia in hip surgery has been shown to reduce the need for opioids and conventional analgesics, facilitate ambulation and early recovery, improve respiratory dynamics, and reduce the incidence of venous thrombosis and pneumonia. Lumbar erector spinae plane block (L-ESPB) has been put forward as a novel ultrasound-guided locoregional technique to relieve pain in hip surgery; however, the supporting evidence remains scarce. Objectives This study aimed to provide evidence on the role of L-ESPB in perioperative pain management during hip surgery. We hypothesized that patients receiving L-ESPB compared to no nerve block would require fewer opioids and experience less pain after hip surgery. The primary outcome was the difference in pain intensity between the L-ESPB group and the control group measured at rest at 2 hours postoperatively using the visual analogue scale (VAS). We compared postoperative analgesic needs and opioid consumption in both groups, assessed the technical difficulty involved in performing L-ESPB, and recorded any side effects in both treatment arms. Finally, we evaluated the level of patient satisfaction. Design This is a pragmatic, single-centre, parallel-group randomized controlled trial in 180 patients. Setting Patients seen at a tertiary care hospital were recruited between June 2024 and May 2025. Patients Inclusion criteria were: age >18 years (irrespective of sex), scheduled for hip surgery, American Society of Anesthesiologists (ASA) class I to III, willing to sign the study informed consent form, and able to understand and use the VAS for pain assessment. Exclusion criteria were: contraindications for the study technique or drugs used, inability to administer the block due to technical barriers, severe cognitive impairment or documented mental disabilities, and current enrolment in another clinical trial. Intervention Patients were randomly assigned in a 1:1 ratio to receive either ultrasound-guided L-ESPB or conventional intravenous analgesia. A total of 180 patients (n = 90, 50% in each group) were enrolled. Data analysis was performed using SPSS. Main outcome measures The primary outcome was resting pain intensity measured using the VAS at 2 hours postoperatively. Results At 2 hours postoperatively, resting VAS pain scores did not differ between groups (L-ESPB [1.81 ± 1.81]; controls: [1.76 ± 1.28]; p = [p = 0.99]).Resting pain scores were slightly lower in the L-ESPB group at 6 and 12 hours; however, the magnitude of the difference was small and did not result in reduced postoperative opioid consumption or rescue analgesic requirements. One patient in the L-ESPB group developed a high neuraxial block requiring intubation and mechanical ventilation for approximately 6 hours, with full recovery and no sequelae. Conclusions Lumbar ESPB did not reduce resting pain at 2 hours after hip surgery and did not reduce postoperative opioid consumption. Small reductions in resting pain scores at 6 and 12 hours were observed, but their clinical relevance is uncertain. Our results do not support routine L-ESPB as a standard analgesic technique for unselected hip surgery patients receiving multimodal analgesia. Further research into this topic is warranted. Clinical trial registration ClinicalTrials.gov NCT06567522; https://www. Clinicaltrials gov/study/NCT06567522. Study protocol doi: https://doi.org/10.2196/75854.